| Overview |
| bsm-62311r-Cy5.5-100ul |
| NAIP Recombinant Antibody, Cy5.5 Conjugated |
| WB |
| Human |
| Specifications |
| Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human NAIP |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 4671 |
| Q13075 |
| Extracellular, Nucleus, Secreted, Cell membrane |
| BIRC1; Birc1a; NAIP; Naip1; NLRB1; psiNAIP. |
| Prevents motor-neuron apoptosis induced by a variety of signals. Possible role in the prevention of spinal muscular atrophy that seems to be caused by inappropriate persistence of motor-neuron apoptosis: mutated or deleted forms of NAIP have been found in individuals with severe spinal muscular atrophy. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz